时间治疗及其在临床中的应用进展
作者：吴春芝;刘红在;岳文;李爽;谷福根;
Author：
收稿日期： 年卷（期）页码：2019,34(06):-643-649
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：时间生物学;生物钟;昼夜节律;时间药动学;时间药效学;时间治疗;临床应用;研究进展
Key words：
基金项目：
中文摘要
时间治疗可改善药物的治疗效果,减少其不良反应,主要适合于心血管疾病、风湿性关节炎、恶性肿瘤、哮喘、胃肠道溃疡等疾病的治疗。现结合近年来国内外时间治疗研究的相关文献,就时间治疗的必要性及在临床中的应用进展进行了综述,旨在为临床更好地开展时间治疗提供重要参考。
参考文献
[1] Welsh DK,Takahashi JS,Kay SA.Suprachiasmatic nucleus:Cell autonomy and network properties[J].Annu Rev Physiol,2010,72:551-577.
[2] Nainwal N.Chronotherapeutics-A chronopharmaceutical approach to drug delivery in the treatment of asthma[J].J Control Rel,2012,163(3):353-360.
[3] Kaur M,Bala R.Chronotherapy:A review[J].Int J Pharm Sci Res,2013,4(1):90-102.
[4] Kaur G,Phillips CL,Wong K,et al.Timing of administration:For commonly-prescribed medicines in Australia[J].Pharmaceutics,2016,8(2):1-18.
[5] 贺前勇,金风,李媛媛.生物钟基因Bmal1与时辰治疗在恶性肿瘤中的研究进展[J].中国肿瘤,2016,25(4):290-296.
[6] Vaughn AR,Clark AK,Sivamani RK,et al.Circadian rhythm in atopic dermatitis-Pathophysiology and implications for chronotherapy[J].Pediatr Dermatol,2018,35(1):152-157.
[7] Levi F,Okyar A.Circadian clocks and drug delivery systems:Impact and opportunities in chronotherapeutics[J].Expert Opin Drug Deliv,2011,8(12):1535-1541.
[8] Dallmann R,Brown SA,Gachon F.Chronopharmacology:New insights and therapeutic implications[J].Annu Rev Pharmacol Toxicol,2014,54:339-361.
[9] Kumar RS,Radha GV,Deepthi KL,et al.An update on chronotherapeutic drug delivery systems[J].Indo Am J Pharm Res,2015,5(9):2857-2880.
[10] Selfridge JM,Gotoh T,Schiffhauer S,et al.Chronotherapy:Intuitive,sound,founded…but not broadly applied[J].Drugs,2016,76(6):1507-1521.
[11] Ballesta A,Innominato PF,Dallmann R,et al.Systems chronotherapeutics[J].Pharmacol Rev,2017,69(2):161-199.
[12] Krakowiak K,Durrington HJ.The role of the body clock in asthma and COPD:Implication for treatment[J].Pulm Ther,2018,4:29-43.
[13] Patil SS,Shahiwala A.Patented pulsatile drug delivery technologies for chronotherapy[J].Expert Opin Ther Patents,2014,24(8):845-856.
[14] Kaur G,Phillips C,Wong K,et al.Timing is important in medication administration:A timely review of chronotherapy research[J].Int J Clin Pharm,2013,35(3):344-358.
[15] Smolensky MH,Hermida RC,Portaluppi F.Circadian mechanisms of 24-hour blood pressure regulation and patterning[J].Sleep Med Rev,2017,33:4-16.
[16] Hermida RC,Ayala DE,Smolensky MH,et al.Sleep-time blood pressure:Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention[J].Sleep Med Rev,2017,33:17-27.
[17] Kario K.Morning surge in blood pressure and cardiovascular risk:Evidence and perspectives[J].Hypertension,2010,56(5):765-773.
[18] Palatini P,Reboldi G,Beilin LJ,et al.Added predictive value of night-time blood pressure variability for cardiovascular events and mortality:The ambulatory blood pressure-international trial[J].Hypertension,2014,64(3):487-493.
[19] Hermida RC,Ayala DE,Fernández JR,et al.Bedtime blood pressure chronotherapy significantly improves hypertension management[J].Heart Failure Clin,2017,13(4):759-773.
[20] Liu X,Liu X,Huang W,et al.Evening-versus morning-dosing drug therapy for chronic kidney disease patients with hypertension:A systematic review[J].Kidney Blood Press Res,2014,39(5):427-440.
[21] Roush GC,Fagard RH,Salles GF,et al.Prognostic impact from clinic,daytime,and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension[J].J Hypertens,2014,32(12):2232-2240.
[22] Stranges PM,Drew AM,Rafferty P,et al.Treatment of hypertension with chronotherapy:Is it time of drug administration?[J].Ann Pharmacother,2015,49(3):323-334.
[23] Smolensky MH,Hermida RC,Ayala DE,et al.Bedtime hypertension chronotherapy:Concepts and patients outcomes[J].Curr Pharm Desi,2015,21(6):773-790.
[24] Yoon HS,Kim SH,Kim JK,et al.Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia[J].Ann Pharmacother,2011,45(7-8):841-849.
[25] Giorgi AD,Menegatti AM,Fabio Fabbian F,et al.Circadian rhythms and medical diseases:Does it matter when drugs are taken?[J].Eur J Intern Med,2013,24(8):698-706.
[26] Cutolo M.Rheumatoid arthritis:Circadian and circannual rhythms in RA[J].Nat Rev Rheumatol,2011,7(9):500-502.
[27] Hideto T.Chronotherapy for rheumatoid arthritis:Current perspectives[J].Chrono Physiology Therapy,2016,6:47-53.
[28] Giangreco D,Cutolo M.Morning glucocorticoids versus night glucocorticoids:The role of low-dose glucocorticoid chronotherapy in rheumatoid arthritis[J].J Clin Rheumatol,2014,20(8):437-439.
[29] Cutolo M,Sulli A,Pincus T.Circadian use of glucocorticoids in rheumatoid arthritis[J].Neuroimmunomodulat,2015,22:33-39.
[30] Krasselt M,Baerwald C.Efficacy and safety of modified?release prednisone in patients with rheumatoid arthritis[J].Drug Des Devel Ther,2016,10:1047-1058.
[31] Alten R,Holt R,Grahn A,et al.Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone[J].Scand J Rheumatol,2015,44(5):354-358.
[32] Subramanian P,Jayapalan JJ,Hashim OH.Chronotherapy:A noteworthy focal point in the treatment of cancer?[J].Biol Rhythm Res,2014,45(5):709-729.
[33] Ozturk N,Ozturk D ,Kavakli IH,et al.Molecular aspects of circadian pharmacology and relevance for cancer chronotherapy[J].Int J Mol Sci,2017,18(10):1-34.
[34] Truong KK,Lam MT,Grandner MA,et al.Timing matters:Circadian rhythm in sepsis,obstructive lung disease,obstructive sleep apnea,and cancer[J].Ann Am Thorac Soc,2016,13(7):1144-1154.
[35] Hsu FM,Hou WH,Huang CY,et al.Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma[J].Chronobiol Int,2016,33(2):210-219.
[36] Chan S,Rowbottom L,McDonald R,et al.Does the time of radiotherapy affect treatment outcomes?A review of the literature[J].Clin Oncol,2017,29(4):231-238.
[37] Durrington HJ,Farrow SN,Ray WD.Recent advances in chronotherapy for the management of asthma[J].Chrono Physiology Therapy,2014,4:125-135.
【关闭】
